News

What will be the next milestone in MS research?

MS Research Australia spoke with some of Australia’s best and brightest minds in the field of MS research. They share information about their current work, milestones, vision for the future and lots more. #BringingUsCloser #RealMSResearch

ofatumumab autoinjector pen

A reminder about PBS listing changes for REBIF and AVONEX

REBIF (interferon beta-1a) and AVONEX (interferon beta-1a) are currently used for the treatment of Australians living with relapsing forms of MS. Recently, there were some changes announced to their listing on the PBS.
autoinjector-pen

Changes announced to AVONEX listing on PBS

From 1 April 2023, AVONEX will no longer be available on the Pharmaceutical Benefits Scheme (PBS) for Australians living with MS.

What us to keep you in the loop? Subscribe today!

  • Enter your details

Read More

Newsletter subscription

  • Enter your details

What will be the next milestone in MS research?